Comment from Frakes Kyle

Summary: Kyle Frakes, Founder of Moonlight Longevity, supports the continued availability of compounded KPV for treating inflammatory conditions like inflammatory bowel disease. He argues that KPV offers a targeted, localized anti-inflammatory effect with a favorable safety profile for patients who do not tolerate current therapies.